Vorsetuzumab Mafodotin (SGN-75) Clinical Trials

TrialTitleStudy Record DetailPhaseSponsor/Colaborator
SGN75-001A Phase I Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell CarcinomaNCT01015911Phase ISeattle Genetics, Inc.
SGN75-002A Phase Ib Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell CarcinomaNCT01677390Phase IbSeattle Genetics, Inc.

Last Editorial Review: August 12, 2015